CHMP Q&A Document on Development and Assessment for Companion Diagnostic Products
The article highlights the key points associated with the regulatory framework for specific categories of medicinal products.
The article highlights the key points associated with the regulatory framework for specific categories of medicinal products.
The article provides an overview of the provisions of a guidance document and highlights the key points to be taken into consideration by medical device manufacturers (software developers).
The article provides an overview of the approach to be applied when calculating regulatory fees associated with registration and authorization for medicines intended to be marketed and used in Ireland.